1-7 of 7
Susan Slovin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pharmacodynamic and Clinical Results from a Phase I/II Study of the HSP90 Inhibitor Onalespib in Combination with Abiraterone Acetate in Prostate Cancer

Susan Slovin, Syed Hussain, Fred Saad, Jorge Garcia, Joel Picus, Roberta Ferraldeschi, Mateus Crespo, Penelope Flohr, Ruth Riisnaes, Chihche Lin, Harold Keer, Aram Oganesian, Paul Workman, Johann de Bono
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (15): 4624–4633.
https://doi.org/10.1158/1078-0432.CCR-18-3212
Published: 01 August 2019
View article titled, Pharmacodynamic and Clinical Results from a Phase I/II Study of the HSP90 Inhibitor Onalespib in Combination with Abiraterone Acetate in Prostate Cancer
Open the PDF for Pharmacodynamic and Clinical Results from a Phase I/II Study of the HSP90 Inhibitor Onalespib in Combination with Abiraterone Acetate in Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Prostate Cancer Progression Correlates with Increased Humoral Immune Response to a Human Endogenous Retrovirus GAG Protein

Bernardo Sgarbi Reis, Achim A. Jungbluth, Denise Frosina, Megan Holz, Erika Ritter, Eiichi Nakayama, Toshiaki Ishida, Yuichi Obata, Brett Carver, Howard Scher, Peter T. Scardino, Susan Slovin, Sumit K. Subudhi, Victor E. Reuter, Caroline Savage, James P. Allison, Jonathan Melamed, Elke Jäger, Gerd Ritter, Lloyd J. Old, Sacha Gnjatic
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (22): 6112–6125.
https://doi.org/10.1158/1078-0432.CCR-12-3580
Published: 14 November 2013
View article titled, Prostate Cancer Progression Correlates with Increased Humoral Immune Response to a Human Endogenous Retrovirus GAG Protein
Open the PDF for Prostate Cancer Progression Correlates with Increased Humoral Immune Response to a Human Endogenous Retrovirus GAG Protein in another window
Includes: Supplementary data
Journal Articles

Phase I Evaluation of J591 as a Vascular Targeting Agent in Progressive Solid Tumors

Michael J. Morris, Neeta Pandit-Taskar, Chaitanya R. Divgi, Samantha Bender, Joseph A. O'Donoghue, Angelo Nacca, Peter Smith-Jones, Lawrence Schwartz, Susan Slovin, Ronald Finn, Steven Larson, Howard I. Scher
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (9): 2707–2713.
https://doi.org/10.1158/1078-0432.CCR-06-2935
Published: 01 May 2007
View article titled, Phase I Evaluation of J591 as a Vascular Targeting Agent in Progressive Solid Tumors
Open the PDF for Phase I Evaluation of J591 as a Vascular Targeting Agent in Progressive Solid Tumors in another window
Journal Articles

Rapid Androgen Cycling as Treatment for Patients with Prostate Cancer

David Feltquate, Luke Nordquist, Caitlin Eicher, Michael Morris, Oren Smaletz, Susan Slovin, Tracy Curley, Andrew Wilton, Martin Fleisher, Glenn Heller, Howard I. Scher
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (24): 7414–7421.
https://doi.org/10.1158/1078-0432.CCR-06-1496
Published: 22 December 2006
View article titled, Rapid Androgen Cycling as Treatment for Patients with Prostate Cancer
Open the PDF for Rapid Androgen Cycling as Treatment for Patients with Prostate Cancer in another window
Journal Articles

Pilot Trial of Unlabeled and Indium-111–Labeled Anti–Prostate-Specific Membrane Antigen Antibody J591 for Castrate Metastatic Prostate Cancer

Michael J. Morris, Chaitanya R. Divgi, Neeta Pandit-Taskar, Maria Batraki, Nyasha Warren, Angelo Nacca, Peter Smith-Jones, Lawrence Schwartz, W. Kevin Kelly, Susan Slovin, David Solit, Jennifer Halpern, Anthony Delacruz, Tracy Curley, Ronald Finn, Joseph A. O'Donoghue, Philip Livingston, Steven Larson, Howard I. Scher
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (20): 7454–7461.
https://doi.org/10.1158/1078-0432.CCR-05-0826
Published: 20 October 2005
View article titled, Pilot Trial of Unlabeled and Indium-111–Labeled Anti–Prostate-Specific Membrane Antigen Antibody J591 for Castrate Metastatic Prostate Cancer
Open the PDF for Pilot Trial of Unlabeled and Indium-111–Labeled Anti–Prostate-Specific Membrane Antigen Antibody J591 for Castrate Metastatic Prostate Cancer in another window
Journal Articles

Fluorodeoxyglucose Positron Emission Tomography as an Outcome Measure for Castrate Metastatic Prostate Cancer Treated with Antimicrotubule Chemotherapy

Michael J. Morris, Timothy Akhurst, Steven M. Larson, Marisa Ditullio, Elaina Chu, Karen Siedlecki, David Verbel, Glenn Heller, W. Kevin Kelly, Susan Slovin, Lawrence Schwartz, Howard I. Scher
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (9): 3210–3216.
https://doi.org/10.1158/1078-0432.CCR-04-2034
Published: 02 May 2005
View article titled, Fluorodeoxyglucose Positron Emission Tomography as an Outcome Measure for Castrate Metastatic Prostate Cancer Treated with Antimicrotubule Chemotherapy
Open the PDF for Fluorodeoxyglucose Positron Emission Tomography as an Outcome Measure for Castrate Metastatic Prostate Cancer Treated with Antimicrotubule Chemotherapy in another window
Journal Articles

Dose Escalation Study of Intravenous Estramustine Phosphate in Combination with Paclitaxel and Carboplatin in Patients with Advanced Prostate Cancer

William Kevin Kelly, Andrew X. Zhu, Howard Scher, Tracey Curley, Mary Fallon, Susan Slovin, Lawrence Schwartz, Steve Larson, William Tong, Beryl Hartley-Asp, Cinzia Pellizzoni, Maurizio Rocchetti
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (6): 2098–2107.
Published: 01 June 2003
View article titled, Dose Escalation Study of Intravenous Estramustine Phosphate in Combination with Paclitaxel and Carboplatin in Patients with Advanced Prostate Cancer
Open the PDF for Dose Escalation Study of Intravenous Estramustine Phosphate in Combination with Paclitaxel and Carboplatin in Patients with Advanced Prostate Cancer in another window